https://www.selleckchem.com/products/bgb-8035.html
BACKGROUND Facial vascularized composite allotransplantation (fVCA) presents an established approach to restore form and function of patients with catastrophic facial defects. Skin is one of the target tissues of the rejection process, and due to its easy accessibility has become the gold standard in the diagnosis of rejection. Mucosal rejection frequently occurs; however, the added value of mucosal rejection assessment for patient management is unknown. METHODS We conducted a systematic review of manuscripts listed in the MEDLINE/PubM
Like
Comment
Share
